Structure Therapeutics Inc
GPCRBuild a strategy around GPCR
Structure Therapeutics Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue pre-clinical biotech burning 196M FCF TTM with 103M cash - runway under 6 months without financing[Free Cash Flow TTM]
- R&D spend of 190M TTM (77% of opex) signals aggressive pipeline investment; 4.2x industry median R&D[Research and Development TTM]
- Trading at 4.6x book with zero revenue - 3.5B market cap pricing in significant clinical success[P/B Ratio]
Watch Triggers
- Cash and Equivalents: Falls below 75M or no financing announced within 90 days — Triggers forced financing at unfavorable terms or strategic sale
- Research and Development TTM: Drops >20% QoQ without pipeline progress — Signals cash preservation mode or abandoned programs
- Net Common Stock Issuance: Exceeds 100M in single quarter — Major dilution event reprices equity significantly
Bull Case
Clean balance sheet (debt/equity 0.9%) with 770M equity provides financing flexibility; recent 57M raise shows capital access
Heavy R&D investment (190M) in GPCR-targeted therapeutics positions for potential blockbuster in obesity/metabolic space
Bear Case
Sub-6-month cash runway at current burn creates existential financing risk; dilution or unfavorable terms likely
3.5B valuation on zero revenue requires multiple clinical wins; binary outcomes typical for pre-revenue biotech
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage GPCR's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Cash runway crisis likely forces dilutive financing or partnership within 6 months
- 103M cash vs 196M annual burn rate
- 57M net stock issuance TTM shows financing pattern
- Working capital 756M mostly invested, not liquid
Valuation Context
Caveats
GPCR Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$9.49B | — | ||
$9.18B | — | ||
0.00 | — | ||
$0 | — | ||
$-2.64 | — | ||
0% | — | ||
0% | — | ||
$-159.22M | — | ||
-15% | +7.9% | — | |
Beta 5Y (Monthly) | unknown | — |
GPCR Dividend History
GPCR Stock Splits
GPCR SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/07/26 | 03/31/26 | 10-Q | |
02/26/26 | 12/31/25 | 10-K | |
11/06/25 | 09/30/25 | 10-Q | |
08/06/25 | 06/30/25 | 10-Q | |
05/08/25 | 03/31/25 | 10-Q | |
02/27/25 | 12/31/24 | Unknown | |
11/13/24 | 09/30/24 | 10-Q | |
08/08/24 | 06/30/24 | 10-Q | |
05/09/24 | 03/31/24 | 10-Q | |
03/08/24 | 12/31/23 | 10-K | |
11/17/23 | 09/30/23 | 10-Q | |
08/10/23 | 06/30/23 | 10-Q | |
05/11/23 | 03/31/23 | 10-Q | |
03/30/23 | 12/31/22 | 10-K | |
02/06/23 | 09/30/22 | 424B4 | |
08/10/23 | 06/30/22 | 10-Q | |
05/11/23 | 03/31/22 | 10-Q | |
02/06/23 | 12/31/21 | 424B4 |